SG Americas Securities LLC Has $12.61 Million Stock Position in Sotera Health Company $SHC

SG Americas Securities LLC increased its position in shares of Sotera Health Company (NASDAQ:SHC) by 6,382.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 879,489 shares of the company’s stock after buying an additional 865,922 shares during the quarter. SG Americas Securities LLC’s holdings in Sotera Health were worth $12,612,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in SHC. Sculptor Capital LP lifted its position in Sotera Health by 57.4% in the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock valued at $370,440,000 after acquiring an additional 7,658,200 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares during the last quarter. Sachem Head Capital Management LP grew its holdings in Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock valued at $205,418,000 after purchasing an additional 3,735,000 shares during the period. Janus Henderson Group PLC grew its holdings in Sotera Health by 4.8% during the fourth quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock valued at $119,460,000 after purchasing an additional 312,191 shares during the period. Finally, State Street Corp increased its position in Sotera Health by 21.0% in the fourth quarter. State Street Corp now owns 5,965,326 shares of the company’s stock worth $105,228,000 after buying an additional 1,035,457 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 15.36% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Weiss Ratings lowered Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Piper Sandler reissued an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, June 5th. They set a “buy” rating and a $20.00 price objective on the stock. Finally, Barclays increased their target price on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $20.25.

Sotera Health Trading Up 1.6%

Shares of SHC stock opened at $17.38 on Friday. The stock has a market capitalization of $4.96 billion, a price-to-earnings ratio of 42.39 and a beta of 1.79. The company’s fifty day simple moving average is $15.79 and its two-hundred day simple moving average is $16.32. Sotera Health Company has a 1 year low of $10.93 and a 1 year high of $19.85. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The firm had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period last year, the company earned $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts anticipate that Sotera Health Company will post 0.88 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.